The Safety Controls IPO is a ₹48 crore book-built issue, consisting entirely of a fresh…

Innovision IPO GMP, Price & Key Details 2026
The Innovision IPO is one of the latest IPOs in 2026, attracting investor interest in the manpower and facility management sector. The company provides services like security, staffing, payroll management, and toll plaza operations across India.

The IPO opened on March 10, 2026, and closed on March 12, 2026. The company aims to raise around ₹323 crore, which includes both fresh issue and offer for sale.
The price band for the IPO is set between ₹521 to ₹548 per share, making it a mid-to-high range IPO for retail investors.
Innovision IPO – Key Details
| Particulars | Details |
|---|---|
| IPO Open Date | March 10, 2026 |
| IPO Close Date | March 12, 2026 |
| Price Band | ₹521 – ₹548 per share |
| Face Value | ₹10 per share |
| Issue Size | ₹322.84 Crore |
| Lot Size | 27 Shares |
| Allotment Date | March 13, 2026 (Expected) |
| Listing Date | March 17, 2026 (Expected) |
| Listing Exchange | BSE & NSE |
GMP (Grey Market Premium)
As per the latest updates, the Innovision IPO GMP is around ₹71, indicating a potential listing gain of around 12–13% over the upper price band.
| Date | IPO GMP | GMP Trend | Gain |
|---|---|---|---|
| 17 March | ₹26 | 5.01% | |
| 16 March | ₹19 | 3.66% | |
| 14 March | ₹7 | 1.35% | |
| 13 March | ₹4 | 0.77% | |
| 12 March | ₹71 | 12.96% |
However, GMP has shown fluctuations. Earlier, it was close to ₹0, reflecting weak sentiment initially.
This means investor sentiment has improved slightly, but still remains somewhat uncertain.
About the Company
Innovision Limited is a Delhi-based company, founded in 2007. It offers:
- Private security services
- Facility management (IFM)
- Manpower sourcing & payroll
- Toll plaza management
- Skill development training
The company operates in 23 states and 5 union territories, serving over 180 clients across sectors like healthcare, retail, logistics, and BFSI.
Final Thoughts
The IPO shows mixed signals:
- Positive: Improving GMP and diversified business
- Negative: Weak initial subscription and fluctuating sentiment
This IPO may be suitable for moderate to long-term investors, while short-term listing gains are not fully certain.

